← Leaderboards
Jonathan J Juliano
Univ Of North Carolina Chapel Hill
$19,413,943
Attributed
$30,095,049
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,095,049 · 15
By mechanism
R01$20,476,637 · 8
K12$4,859,730 · 1
T32$1,467,867 · 1
K24$1,391,423 · 1
R21$880,389 · 2
U19$867,003 · 1
Top collaborators
- Rhoel David Ramos Dinglasan14 shared
- Sandrine Nsango7 shared
- Jeffrey A. Bailey4 shared
- Jessica Lin4 shared
- Jean Baptiste Mazarati4 shared
- Billy Ngasala4 shared
- Michelle Hernandez3 shared
- Steven Richard Meshnick3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jessica Lin$6,116,433
- Sandrine Nsango$941,674
- Billy Ngasala$938,673
- Carla J Cerami$1,029,234
- Kelly Carey-Ewend$89,178
Others in their field
Top investigators on “Parasites”
- Stephen Lev Hoffman · Sanaria, Inc.$58,168,134
- L David Sibley · Washington University$47,818,729
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,087,946
- Wilhelmus G. J. Hol · University Of Washington$32,390,237
- Philip Jon Rosenthal · University Of California San Francisco$31,794,731
- Daniel F. Hoft · Saint Louis University$31,137,771
Research focus
ParasitesMalariaAfricaSamplingInfectionPlasmodium FalciparumMolecularTransmission ProcessResistanceGeneticSiteGenotypeProgramsGenesCountryDrug ResistanceArtemisininsCombined Modality TherapyBiologyAreaDemocratic Republic Of The CongoMonitorCommunitiesPublic Health
Grant awards (66)
CTSA K12 Program at UNC$1,620,000
K12 · FY2025 · TR
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$607,415
R01 · FY2025 · AI · contact PI
Predicting the spread of antimalarial drug resistance using deep learning surrogates$498,885
R01 · FY2025 · AI · contact PI
Predicting the spread of antimalarial drug resistance using deep learning surrogates$204,922
R01 · FY2025 · AI · contact PI
Mentoring in Translational Malaria Genomics$172,941
K24 · FY2025 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$69,638
R01 · FY2025 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$46,558
R01 · FY2025 · AI · contact PI
CTSA K12 Program at UNC$1,619,730
K12 · FY2024 · TR
Importation and transmission of malaria in Zanzibar: a case study for elimination$753,731
R01 · FY2024 · AI · contact PI
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda$715,370
R01 · FY2024 · AI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$693,422
R01 · FY2024 · AI · contact PI
Infectious Disease Pathogenesis Research Training Program$287,822
T32 · FY2024 · AI · contact PI
Mentoring in Translational Malaria Genomics$172,941
K24 · FY2024 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$77,596
R01 · FY2024 · AI · contact PI
CTSA K12 Program at UNC$1,620,000
K12 · FY2023 · TR
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda$717,215
R01 · FY2023 · AI
Importation and transmission of malaria in Zanzibar: a case study for elimination$695,910
R01 · FY2023 · AI · contact PI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$649,572
R01 · FY2023 · AI · contact PI
Infectious Disease Pathogenesis Research Training Program$302,762
T32 · FY2023 · AI · contact PI
Parasite Genetics Core$197,433
U19 · FY2023 · AI · contact PI
Mentoring in Translational Malaria Genomics$173,221
K24 · FY2023 · AI · contact PI
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda$727,201
R01 · FY2022 · AI
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline$680,820
R01 · FY2022 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$664,108
R01 · FY2022 · AI · contact PI
Importation and transmission of malaria in Zanzibar: a case study for elimination$640,900
R01 · FY2022 · AI · contact PI
Infectious Disease Pathogenesis Research Training Program$289,957
T32 · FY2022 · AI · contact PI
Mentoring in Translational Malaria Genomics$174,464
K24 · FY2022 · AI · contact PI
Parasite Genetics Core$137,039
U19 · FY2022 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$1,779
R01 · FY2022 · AI · contact PI
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda$794,882
R01 · FY2021 · AI
Importation and transmission of malaria in Zanzibar: a case study for elimination$725,478
R01 · FY2021 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$708,641
R01 · FY2021 · AI · contact PI
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite Populations$479,595
R01 · FY2021 · TW · contact PI
Infectious Disease Pathogenesis Research Training Program$285,014
T32 · FY2021 · AI · contact PI
Parasite Genetics Core$228,603
U19 · FY2021 · AI · contact PI
Mentoring in Translational Malaria Genomics$174,464
K24 · FY2021 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$47,586
R01 · FY2021 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$717,783
R01 · FY2020 · AI · contact PI
Variation in Resistance and Fitness to Artemisinins in African Malaria$671,948
R01 · FY2020 · AI · contact PI
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite Populations$470,099
R01 · FY2020 · TW · contact PI
Infectious Disease Pathogenesis Research Training Program$302,312
T32 · FY2020 · AI · contact PI
Mentoring in Translational Malaria Genomics$174,464
K24 · FY2020 · AI · contact PI
Parasite Genetics Core$152,314
U19 · FY2020 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$710,593
R01 · FY2019 · AI · contact PI
Variation in Resistance and Fitness to Artemisinins in African Malaria$680,308
R01 · FY2019 · AI · contact PI
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite Populations$466,171
R01 · FY2019 · TW · contact PI
Mentoring in Translational Malaria Genomics$174,464
K24 · FY2019 · AI · contact PI
Parasite Genetics Core$151,614
U19 · FY2019 · AI · contact PI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives$758,337
R01 · FY2018 · AI · contact PI
Variation in Resistance and Fitness to Artemisinins in African Malaria$673,774
R01 · FY2018 · AI · contact PI
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite Populations$478,822
R01 · FY2018 · TW · contact PI
Mentoring in Translational Malaria Genomics$174,464
K24 · FY2018 · AI · contact PI
Variation in Resistance and Fitness to Artemisinins in African Malaria$632,307
R01 · FY2017 · AI · contact PI
Collaborative Research: Impacts of the African Origin of Plasmodium vivax on Contemporary Parasite Populations$480,406
R01 · FY2017 · TW · contact PI
Diversity and Phenotype of Artemisinin Resistance Mutations in Central Africa$193,496
R21 · FY2017 · AI · contact PI
Variation in Resistance and Fitness to Artemisinins in African Malaria$675,404
R01 · FY2016 · AI · contact PI
Diversity and Phenotype of Artemisinin Resistance Mutations in Central Africa$244,800
R21 · FY2016 · AI · contact PI
Dissecting Chloroquine Resistance in the Plasmodium vivax Cross$195,111
R21 · FY2015 · AI · contact PI
Within Host Selection of P. falciparum Variants by Artemisinin Combination Therap$329,671
R01 · FY2014 · AI · contact PI
Dissecting Chloroquine Resistance in the Plasmodium vivax Cross$246,982
R21 · FY2014 · AI · contact PI
Effects of Daily Cotrimoxazole on Malaria in HIV Exposed, Uninfected Infants$76,000
R03 · FY2014 · AI · contact PI
Within Host Selection of P. falciparum Variants by Artemisinin Combination Therap$306,961
R01 · FY2013 · AI · contact PI
Effects of Daily Cotrimoxazole on Malaria in HIV Exposed, Uninfected Infants$76,000
R03 · FY2013 · AI · contact PI
Within Host Selection of P. falciparum Variants by Artemisinin Combination Therap$553,975
R01 · FY2012 · AI · contact PI
Within Host Selection of P. falciparum Variants by Artemisinin Combination Therap$326,734
R01 · FY2011 · AI · contact PI
Within Host Selection of P. falciparum Variants by Artemisinin Combination Therap$342,120
R01 · FY2010 · AI · contact PI